✦ LIBER ✦

Drug monitoring and pharmacokinetics of a methotrexate-albumin conjugate (MTX-HSA) in cancer patients with long term remission

✍ Scribed by Hartung, G.; Stehle, G.; Heeger, S.; Kränzle, M.; Wunder, A.; Bertsch, T.; Köpke, J.; Spacek, S.; Sinn, H.; Queißer, W.

Book ID: 122512323
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 116 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81608-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I-trial of a methotrexate — Albumi

Phase I-trial of a methotrexate — Albumin conjugate (MTX-HSA) in cancer patients

✍ Hartung, G.; Stehle, G.; Sinn, H.; Schrenk, H.H.; Heeger, S.; Kränzle, M.; Fiebi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Biodistribution of a monoclonal antibody

Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer

✍ K. C. Ballantyne; A. C. Perkins; M. V. Pimm; M. C. Garnett; Jane A. Clegg; N. C. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 547 KB

The monoclonal antibody (MAb) 791T/36 which has previously been shown to localise in colorectal cancer has been conjugated to methotrexate (MTX) for potential use as a chemotherapeutic agent in malignant disease. To examine its biodistribution and tumour localisation, 16 patients with primary colore

A dose finding and pharmacokinetic study

A dose finding and pharmacokinetic study of docetaxel (TXT) and methotrexate (MTX) in patients with epithelial cancer

✍ Zanetta, S.; Guillot, A.; Ardiet, C.; Tranchand, B.; Dumortier, A.; Bernard, E.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Long-Term Survival Results of a Randomiz

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, with Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients with Bladder Cancer

✍ von der Maase, H.; Sengelov, L.; Roberts, J.T.; Ricci, S.; Dogliotti, L.; Oliver 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 35 KB

726 - Long-term weekly treatment of adva

726 - Long-term weekly treatment of advanced colorectal cancer (CRC) with fluorouracil (5-FU) and leucovorin (LV): 5 year-results of a multicentric phase II trial of 5-FU pharmacokinetic monitoring in 152 patients

✍ B. Lamezec; C. Alleaume; E. Gamelin; M.J. Goudier; P.E. Cailleux; E. Danquechin- 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

5020 Pharmacokinetics (PK), safety, and

5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and phase II trial results

✍ H. Burris III; S. Vukelja; I. Krop; S. Modi; B. Klencke; S. Girish; M.X. Sliwkow 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB